Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19: a retrospective pilot study.

Katharina Hoeter,Elmo Neuberger,Susanne Fischer,Manuel Herbst, Ema Juškevičiūtė,Kira Enders,Heidi Rossmann,Martin F Sprinzl,Perikles Simon,Marc Bodenstein, Michael Schaefer

PeerJ（2023）

引用 1|浏览3

暂无评分

摘要

The results of this observational pilot study show a wide range in cfDNA plasma concentrations in patients with COVID-19 during the first wave of infection and confirm that cfDNA plasma concentrations serve as a predictive biomarker of disease severity in COVID-19.

查看译文

关键词

COVID-19,Sars-CoV-2,Cell free DNA,Organ dysfunction,Clinical outcome

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要